In this session, the presenters will define what cardiac amyloid is; red flags, recognition, diagnostics crucial to diagnosis, treatment and management of idiosyncracies of amyloid that require special precautions/management.

This webinar will provide an overview of the spectrum of coronary dysfunction, including coronary microvascular dysfunction and vasospastic disease. Attendees will review contemporary concepts in pathophysiology, diagnosis, prognosis, and treatment, while exploring practical implications for cardiac rehabilitation professionals.

This 60-minute webinar, recorded in August 2026, will outline a scalable lifestyle medicine approach to rehabilitation for this population. Using the University Health Network ACHD Lifestyle Medicine Program as a case example, the session will review the program structure and the clinical rationale for integrating exercise, principles for prescribing aerobic and resistance exercise, and strategies to scale exercise across varying levels of function and resources.

This introductory session, recorded in July 2026, makes the case for pediatric cardiac rehabilitation, addressing long-standing misconceptions about exercise restriction and reviewing the physiologic and psychosocial benefits of physical activity across the spectrum of congenital heart disease.

This session, recorded in August 2026, will explore the common reasons for patient nonadherence. Presenters will discuss innovative tools and techniques to overcome these obstacles to improve patient engagement, adherence, and long-term cardiovascular outcomes.

This session, recorded in August 2026, will demonstrate how the CRCP can serve as a strategic tool to increase enrollment.

This session will examine the referral process from inpatient care to outpatient cardiac rehabilitation, highlighting opportunities to strengthen transitions across the continuum of care.

This session introduces the Cardiac Rehab Change Package and highlights key resources available through AACVPR, including those from the TAKEheart initiative. We will explore strategies for driving system-level change to elevate the role of cardiac rehabilitation, with a focus on administrative support, staffing models and compensation structures.

In this session, the presenter will discuss how masters athletes (individuals >35 years) increasingly undergo cardiovascular evaluation, raising important questions about risk stratification, imaging interpretation, and safe participation in sport. Clinicians and athletes often ask: Which findings represent physiologic adaptation versus disease? Which imaging or exercise test results signal higher risk? And how should current guideline recommendations be applied to competitive older athletes?

In this session, the presenter will provide an update on the key recommendations for secondary prevention as per the 2026 ACC/AHA/AACVPR Guideline on the Management of Dyslipidemia, and an overview of clinical studies and pharmacologic actions of novel lipid therapies.